Respirogen Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Respirogen General Information

Description

Operator of a bio-science company intended to offer therapeutic oxygen delivery services. The company's services include technologies for blood oxygenation in critical care scenarios through oxygen micro-bubbles technology, enabling healthcare providers to stabilize and deliver oxygen for numerous medical applications easily.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6560 Odell Place
  • Suite E
  • Boulder, CO 80301
  • United States
+1 (303)
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
  • 6560 Odell Place
  • Suite E
  • Boulder, CO 80301
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Respirogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 07-Jun-2026 Completed Out of Business
5. Accelerator/Incubator 02-Nov-2021 Completed Generating Revenue
4. Angel (individual) 12-Jun-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 20-Sep-2018 Completed Generating Revenue
2. Accelerator/Incubator 30-Mar-2018 $15K Completed Generating Revenue
1. Angel (individual) 19-May-2017 $15K $15K Completed Generating Revenue
To view Respirogen’s complete valuation and funding history, request access »

Respirogen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Respirogen’s complete cap table history, request access »

Respirogen Patents

Respirogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220040393-A1 Device and method for attenuation of co2 in circulating blood Inactive 04-Aug-2020
US-11597576-B2 Packaging for pressure and gas sensitive products Active 18-Feb-2020
US-20210253326-A1 Packaging for pressure and gas sensitive products Active 18-Feb-2020
US-20210038488-A1 Oxygenated skin lotion Inactive 23-Apr-2018
WO-2019209722-A1 Oxygenated skin lotion Inactive 23-Apr-2018 A61K31/658
To view Respirogen’s complete patent history, request access »

Respirogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Respirogen FAQs

  • When was Respirogen founded?

    Respirogen was founded in 2017.

  • Where is Respirogen headquartered?

    Respirogen is headquartered in Boulder, CO.

  • What is the size of Respirogen?

    Respirogen has 4 total employees.

  • What industry is Respirogen in?

    Respirogen’s primary industry is Drug Delivery.

  • Is Respirogen a private or public company?

    Respirogen is a Private company.

  • What is Respirogen’s current revenue?

    The current revenue for Respirogen is .

  • How much funding has Respirogen raised over time?

    Respirogen has raised $1.26M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process